At its core, the design intent was to draw visitors and staff to the new device lab. The lab, while designed to inspire innovation among the company’s researchers and developers, also serves as a destination for outside visitors – showing off its capabilities and educating individuals about the client’s devices. To succeed in this mission, the building had to undergo a dramatic transformation from its initial usage as a standard laboratory building to a showcase piece that emphasized the client’s areas of focused growth, such as Human Factors and E-health. The renovated building, consisting of two floors that place emphasis on the combination of medical devices with biologic products, is a truly accessible central hub of activity.
A New Hub for Emerging Technologies
Confidential Client
Lexington, MA
When a longtime biopharmaceutical client, recently acquired by a global pharmaceutical company, merged with another biopharmaceutical company based in Illinois, SMMA worked with the organization to co-locate its expertise in medical devices and support functions to better foster collaboration, innovation, and efficient operations. The client’s building at 125 Spring Street in Lexington, MA, has served many purposes: first as a space for Raytheon and then as a wet lab research facility. Before the merger, the space included a variety of program types, from labs to offices to a vivarium.
As part of the overall co-location strategy, the client’s biologics team moved to Cambridge, Massachusetts, thus freeing up 125 Spring Street to be transformed into a Center of Excellence for Medical Devices. The new Center functions as a hub for the exploration of next-generation therapeutics, emerging technologies, and new care models that can help improve patient health.
